Deepak Fertilizers & Petrochemicals Corp Ltd
Incorporated in 1979, Deepak Fertilisers and Petrochemicals Corporation Ltd is in the business of fertlisers, agri services, bulk chemicals, mining chemicals and real estate[1]
- Market Cap ₹ 19,862 Cr.
- Current Price ₹ 1,576
- High / Low ₹ 1,612 / 579
- Stock P/E 48.1
- Book Value ₹ 276
- Dividend Yield 0.54 %
- ROCE 15.0 %
- ROE 12.4 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 94.3% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 36.0%
Cons
- Stock is trading at 5.71 times its book value
- The company has delivered a poor sales growth of 2.70% over past five years.
- Company has a low return on equity of 10.4% over last 3 years.
- Earnings include an other income of Rs.254 Cr.
- Working capital days have increased from 59.3 days to 142 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Part of BSE 500 Nifty 500 BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
3,801 | 3,708 | 4,243 | 2,057 | 3,187 | 3,149 | 1,708 | 1,811 | 2,289 | 2,350 | 1,923 | 1,951 | |
3,294 | 3,409 | 3,881 | 1,829 | 3,000 | 3,033 | 1,596 | 1,424 | 1,962 | 1,976 | 1,588 | 1,560 | |
Operating Profit | 507 | 298 | 362 | 228 | 187 | 116 | 112 | 387 | 327 | 374 | 334 | 390 |
OPM % | 13% | 8% | 9% | 11% | 6% | 4% | 7% | 21% | 14% | 16% | 17% | 20% |
33 | 37 | 52 | 15 | 65 | 23 | 68 | 45 | 88 | 134 | 199 | 254 | |
Interest | 101 | 110 | 129 | 53 | 71 | 80 | 85 | 87 | 69 | 51 | 40 | 39 |
Depreciation | 103 | 117 | 118 | 53 | 50 | 48 | 72 | 73 | 80 | 67 | 81 | 86 |
Profit before tax | 336 | 108 | 168 | 137 | 131 | 11 | 22 | 272 | 266 | 390 | 413 | 519 |
Tax % | 28% | 28% | 28% | 34% | 14% | 29% | -40% | 23% | 26% | 25% | 24% | 20% |
244 | 78 | 120 | 90 | 113 | 8 | 31 | 209 | 198 | 291 | 313 | 413 | |
EPS in Rs | 24.05 | 7.73 | 11.82 | 8.91 | 11.13 | 0.78 | 2.99 | 20.35 | 16.40 | 23.08 | 24.82 | 32.72 |
Dividend Payout % | 24% | 45% | 37% | 59% | 47% | 334% | 87% | 37% | 55% | 43% | 34% | 31% |
Compounded Sales Growth | |
---|---|
10 Years: | -6% |
5 Years: | 3% |
3 Years: | -5% |
TTM: | 1% |
Compounded Profit Growth | |
---|---|
10 Years: | 19% |
5 Years: | 94% |
3 Years: | 29% |
TTM: | 53% |
Stock Price CAGR | |
---|---|
10 Years: | 31% |
5 Years: | 73% |
3 Years: | 32% |
1 Year: | 159% |
Return on Equity | |
---|---|
10 Years: | 8% |
5 Years: | 10% |
3 Years: | 10% |
Last Year: | 12% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 88 | 88 | 88 | 88 | 88 | 88 | 89 | 103 | 121 | 126 | 126 | 126 |
Reserves | 1,403 | 1,437 | 1,483 | 1,477 | 1,528 | 1,518 | 1,549 | 1,908 | 2,606 | 2,869 | 3,049 | 3,357 |
962 | 1,384 | 1,948 | 1,329 | 1,368 | 674 | 801 | 780 | 570 | 366 | 359 | 421 | |
706 | 555 | 925 | 441 | 653 | 737 | 515 | 471 | 488 | 487 | 469 | 546 | |
Total Liabilities | 3,159 | 3,464 | 4,445 | 3,335 | 3,637 | 3,017 | 2,954 | 3,262 | 3,785 | 3,848 | 4,004 | 4,451 |
1,388 | 1,351 | 1,263 | 762 | 719 | 700 | 1,106 | 1,040 | 1,037 | 1,034 | 1,048 | 1,034 | |
CWIP | 94 | 141 | 395 | 92 | 194 | 506 | 23 | 24 | 11 | 19 | 33 | 207 |
Investments | 305 | 301 | 138 | 959 | 1,116 | 835 | 823 | 934 | 1,153 | 1,985 | 1,740 | 1,772 |
1,372 | 1,671 | 2,649 | 1,522 | 1,609 | 976 | 1,002 | 1,264 | 1,585 | 810 | 1,182 | 1,438 | |
Total Assets | 3,159 | 3,464 | 4,445 | 3,335 | 3,637 | 3,017 | 2,954 | 3,262 | 3,785 | 3,848 | 4,004 | 4,451 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
414 | -73 | -99 | -7 | -224 | 830 | -34 | 457 | 392 | 247 | 121 | 252 | |
-62 | -191 | -61 | 106 | 319 | -48 | 61 | -590 | -608 | 40 | 71 | -122 | |
-357 | 209 | 318 | -225 | -104 | -813 | 22 | 67 | 224 | -294 | -190 | -71 | |
Net Cash Flow | -6 | -55 | 158 | -126 | -8 | -31 | 50 | -66 | 8 | -7 | 3 | 59 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 74 | 92 | 132 | 89 | 119 | 51 | 88 | 50 | 19 | 25 | 53 | 49 |
Inventory Days | 46 | 51 | 66 | 33 | 30 | 17 | 26 | 40 | 27 | 29 | 36 | 53 |
Days Payable | 47 | 29 | 52 | 51 | 65 | 69 | 84 | 78 | 57 | 56 | 51 | 67 |
Cash Conversion Cycle | 73 | 114 | 146 | 72 | 84 | -1 | 30 | 11 | -11 | -2 | 38 | 35 |
Working Capital Days | 51 | 89 | 127 | 115 | 83 | -1 | 20 | 20 | -6 | 15 | 21 | 142 |
ROCE % | 18% | 8% | 9% | 6% | 7% | 3% | 3% | 14% | 11% | 13% | 11% | 15% |
Documents
Announcements
- Communication To Shareholders Regarding Compulsory Transfer Of Equity Shares Of The Company To The Investor Education And Protection Fund ('IEPF') 1m
-
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
7h - PCL allotted 63,286 shares to DMSL converting Rs.1044.85 Cr ICD; shareholding unchanged.
-
Board Meeting Outcome for Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
1d - Project cost revised to ₹1,982.79 Cr for new acid plants at Dahej, Gujarat.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
28 May - Of Newspaper Publication under Regulation 30 of the SEBI (LODR) Regulations, 2015 .
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
28 May - Deepak Fertilisers Q4 FY25: 18% revenue growth, 102% PAT growth, specialty products 22%, CAPEX ongoing, net debt reduced.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2012
from nse
-
Financial Year 2011
from bse
Concalls
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT REC
-
Jun 2024Transcript PPT REC
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT
-
Nov 2023TranscriptNotesPPT
-
Aug 2023Transcript PPT REC
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Dec 2022Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Jan 2022TranscriptNotesPPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jun 2021Transcript PPT
-
Feb 2021TranscriptPPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Aug 2020Transcript PPT
-
Jul 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Dec 2019Transcript PPT
-
Sep 2019TranscriptNotesPPT
-
Aug 2019Transcript PPT
-
Jul 2019TranscriptPPT
-
Jun 2019Transcript PPT
-
Apr 2019TranscriptNotesPPT
-
Feb 2019TranscriptNotesPPT
-
Nov 2018TranscriptNotesPPT
-
Aug 2018TranscriptNotesPPT
Leadership[1]
- Only manufacturer of Prilled and Medical-grade Ammonium Nitrate in India
- Leading manufacturer and marketer of IPA in India.
- Only manufacturer of NP prill 24:24:0 fertilizer in India
- Market leader in Bentonite Sulphur, specialty and water-soluble fertilizers in India.